Citizens all over the world, including Malaysians, have been encouraged to take the Covid-19 vaccine to create herd immunity and finally put an end to the pandemic.

However, there are exceptions, as some categories of people are not encouraged to take the vaccine shots, while others are totally not allowed to be vaccinated, including with the Pfizer-BioNTech Covid-19 vaccine known as Comirnaty.

According to the Frequently Asked Questions (FAQ) section on the National Pharmaceutical Regulatory Agency (NPRA) website about the Comirnaty vaccine, individuals who are immunocompromised, autoimmune patients, pregnant women or those breastfeeding are among those not recommended to take the vaccine.

This is because, currently, there is insufficient clinical evidence to support the use of the vaccine among those groups, but that may change after more clinical data is obtained.

"The Comirnaty vaccine clinical trials also did not involve pregnant women or those breastfeeding… as there is no data on the effectiveness and safety of the vaccine on that population, they are discouraged from taking the vaccine until further information is obtained,” according to the NPRA.

The Comirnaty vaccine also cannot be given to individuals with allergic reaction to any substance in the vaccine, including messenger ribonucleic acid (mRNA), lipids, polyethylene glycol, potassium chloride, potassium dihydrogen phosphate, sodium chloride, disodium phosphate dihydrate and sucrose.

In addition, the second dose should not be given to individuals suffering from serious allergic reactions after receiving the first dose, the NPRA said.

"Please seek a doctor’s advice if you have any form of allergy, bleeding problems or are taking any blood thinners if you are undergoing or have just completed cancer treatment, an organ transplant or stem cell treatment.

"Also, if you have been infected with Covid-19, have received other Covid-19 vaccines, either through an immunisation programme or as a subject in a Covid-19 clinical test, or have received passive antibody treatment for Covid-19,” the NPRA added.

The vaccine, which has been approved by the Drug Control Authority (DCA), is currently for individuals who are 18 years and above.

"This is due to insufficient data to determine the effectiveness and safety of the vaccine on those 18 years and below… that is why children under 18 cannot be provided immunisation until further data is obtained,” the NPRA said.

'Only trust information on the NPRA website'

Meanwhile, Malaysian Pharmacists Society president Amrahi Buang said the public should rely on and only trust information on the NPRA website, and not believe rumours or speculation from other countries.

He said the NPRA always updates and amends the Comirnaty vaccine FAQ section with new information about the vaccine as soon as it has obtained the latest information, either from Pfizer itself, or from the sharing of global data with other countries.

"So the public is advised not to come to their own conclusions… it is better to let expert doctors make the decision whether or not to take the vaccine during vaccination day because there are many different diseases with varying levels of severity.

"Prime Minister Muhyiddin Yassin, for example, although he is a cancer survivor, he will take the vaccination shot because his doctor said he can,” Amrahi said.

Regarding Sinovac, he said although the China vaccine will arrive on Feb 27, information about the vaccine has yet to be made available on the NPRA website as it has not been registered in the country.

"The vaccine will arrive in the country in bulk before the 'fill and finish' process is completed in the factory owned by Pharmaniaga here; only then can they apply to register with the NPRA so that the DCA can issue a conditional registration,” Amrahi said.

Malaysian Public Health Physicians Association president Dr Zainal Ariffin Omar meanwhile said that those without any critical or serious illness should not be afraid to take the vaccine as it is safe.

"The shots are not simply given; the doctor will evaluate the risk and question and check the medical history as well as any allergies before making a decision whether the vaccine is suitable or not.

"For pregnant women, for example, there are experts who think that if it’s in the third trimester, the vaccine can be taken… that is why it is better to discuss with the doctor to be sure… that is best,” Zailan Ariffin said.

- Bernama